Clinical and pathological correlates of apolipoprotein ε4 in Alzheimer's disease

Annals of Neurology

Volumn 39, Issue 1, 1996, Pages 62-70

  Gomez Isla, Teresa ^a   West, Howard L ^a   Rebeck, G William ^a   Harr, Steven D ^a   Growdon, John H ^a   Locascio, Joseph J ^a   Perls, Thomas T ^b   Lipsitz, Lewis A ^b   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; FEMALE; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BASE SEQUENCE; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 0030050286     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390110     Document Type: Article

References (60)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630
2. Ordovas JM, Litwack-Klein L, Wilson PWF, et al. Apolipo-protein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987;28:371-380
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
4. Poirter J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699
5. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheirner's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580
6. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
7. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequence of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
8. Tsai M-S, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54: 643-649
9. Chartier-Harlin M-C, Parfitt M, Legiain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994,3:569-574
10. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120
11. Strittmatter WJ, Weisgraber KH, Huang D, er al. Binding of human apolipoprotein E to βA4 peptide: isoform specific effects and implications for late onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102
12. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
13. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238
14. Wisniewski T, Golabek A, Matsubara E, et al. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993;192:359-365
15. Strittmatter WJ, Weisgrabber KH, Goedert M, et al. Hypothesis: microtubulc instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171
16. Han S-H, Einstein G, Weisgraber KH, et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 1994;53:535-544
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA group under the auspices of Department of HHS Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
18. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811
19. Weintraub S. The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimer Care 1986;1:35-39
20. Folstein M, Folstein S, McHugh P. "Mini-mental stare": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
21. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
22. Hyman BT, Tanzi RE, MarzlofF KM, et al. Kunitz protease inhibitor containing amyloid precursor protein immunoreactivity in Alzheimer's disease: a quantitative study. J Neuropathol Exp Neurol 1992;51:76-83
23. Vincent I, Davies P. A protein kinase associated with paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci USA 1992;89:2878-2882
24. Yeterian E, Pandya D. The association cortices. In: Jones EG, Peters A, eds. Cerebral cortex, vol. 5. New York: Plenum Press, 1989:1-53
25. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116
26. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer disease. Neurology 1992;42:631-639
27. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993;52:594-600
28. West M. New stereological methods for counting neurons. Neurobiol Aging 1993;14:275-285
29. Lucotte G, Turpin J-C, Landais P. Apolipoprotein E ε4 allele doses in late onset Alzheimer's disease. Ann Neurol 1994;36: 681-682
30. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711
31. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: b-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437
32. Mui S, Rebeck GW, McKenna-Yasek D, et al. Apolipoprotein E ε4 allele is not associated with earlier age of onset in sporadic or familial amyotrophic lateral sclerosis. Ann Neurol 1995;38: 460-463
33. Gearing M, Schneider JA, Rebeck GW, et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathological correlates. Neurology 1995 (in press)
34. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-245
35. Corder E, Saunders A, Strittmatter W, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995,45: 1323-1328
36. Frisoni G, Govoni S, Geroldi C, et al. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in late-onset Alzheimer's disease. Ann Neurol 1995;37:596-604
37. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
38. Corder EH, Saunders AM, Risch NJ, et al. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet 1994;7:180-184
39. Payami H, Montee K, Kaye J, et al. Alzheimer's disease, apolipoprotein E and gender. JAMA 1994:1316-1317 (Letter)
40. Corder E, Saunders A, Strittmatter W, et al. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease JAMA 1995;273:373-374 (Letter)
41. Goate A, Chartier-Harlin M-C, Mullan M. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-707
42. Hyman BT. Studying the Alzheimer's disease brain: insights, puzzles, and opportunities. Neurobiol Aging 1994;15:S79-S83
43. Berg L, McKeel DW, Miller JP, et al. Neuropathological indexes of Alzheimer's disease m demented and nondemented persons aged 80 and older. Arch Neurol 1993;50:349-358
44. Bouras C, Hof P, Giannakopoulos P, et al. Regional distribu tion of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population in a geriatric hospital. Cereb Cortex 1994;4:138-150
45. Hyman BT, West HL, Rebeck GW, et al. Neuropathological changes in Down's syndrome hippocampal formation: effect of age and apolipoprotein E genotype. Arch Neurol 1995;52: 373-378
46. LaDu MJ, Falduto MT, Manelli AM, et al. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994, 269:23403-23406
47. 2-macroglobulin receptor/low-density-lipoprotein receptor-related prorein. Ann Neurol 1995; 37:211-217
48. Terry RD, Masliah E, Salmon DP. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;41: 572-580
49. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease; correlation with cognitive severity. Ann Neurol 1990;27:457-464
50. Hansen L, Galasko D, Samuel W, et al. Apolipoprotein E ε4 is associated with increased neurofibrillary tangles in the Lewy body variant of Alzheimer's disease. Neurosci Lett 1994;182: 63-65
51. Ohm T, Kirca M, Bohl J, et al. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995;66:583-587
52. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimers disease. Proc Natl Acad Sci USA 1993;90:9649-9653
53. Zubenko GS, Stiffler S, Stabler S, et al. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Hum Genet 1994, 54:199-205
54. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484
55. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995;92:3586-3590
56. Greenberg S, Rebeck GW, Vonsattel JPG, et al. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259
57. Berr C, Hauw JJ, Delaere P, et al. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett 1994;178:221-224
58. Cai X-D, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-516
59. Citron M, Oltersdorf T, Haass C, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-674
60. Suzuki N, Cheung TT, Cai X-D, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994;264:1336-1340